Smoking and lipid-related indices in patients with diabetes mellitus

Diabetic Medicine

Volumn 31, Issue 7, 2014, Pages 868-878

  Wakabayashi, I ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; HUMAN; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; SMOKING; ADVERSE EFFECTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; DIABETIC ANGIOPATHIES; DRINKING BEHAVIOR; FEMALE; JAPAN; METABOLISM; MIDDLE AGED; QUESTIONNAIRE; RISK; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; AGED; ALCOHOL DRINKING; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; JAPAN; LIPIDS; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RISK FACTORS; SMOKING; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84925884657     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12430     Document Type: Article

References (40)

1. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004; 43: 1731-1737.
2. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. Br Med J 1989; 298: 784-788.
3. Gepner AD, Piper ME, Johnson HM, Fiore MC, Baker TB, Stein JH. Effects of smoking and smoking cessation on lipids and lipoproteins: outcomes from a randomized clinical trial. Am Heart J 2011; 161: 145-151.
4. Zaratin ACM, Quintão ECR, Sposito AC, Nunes VS, Lottenberg AM, Morton RE et al. Smoking prevents the intravascular remodeling of high-density lipoprotein particles: implications for reverse cholesterol transport. Metabolism 2004; 53: 858-862.
5. The Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-841.
6. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2009; 5: 150-159.
7. Dunn FL. Management of dyslipidemia in people with type 2 diabetes mellitus. Rev Endocr Metab Disord 2010; 11: 41-51.
8. Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985; 110: 1100-1107.
9. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997; 96: 2520-2525.
10. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease: An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 1997; 17: 1114-1120.
11. HDL). Clin Biochem 2001; 34: 583-588.
12. Kahn HS. The 'lipid accumulation product' performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord 2005; 5: 26.
13. Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care 2006; 29: 151-153.
14. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women. Obesity (Silver Spring) 2011; 19: 1873-1880.
15. Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB et al. Alcohol and blood lipids. The Cooperative Lipoprotein Phenotyping Study. Lancet 1977; 2: 153-155.
16. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation 1992; 85: 910-915.
17. Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides. Int J Vasc Med 2012; 2012: 862504.
18. Wakabayashi I. Increased body mass index modifies associations between alcohol intake and blood cholesterol profile. Eur J Clin Invest 2012; 42: 179-185.
19. Wakabayashi I. Inverse association between triglycerides-to-HDL-cholesterol ratio and alcohol drinking in middle-aged Japanese men. J Stud Alcohol Drugs 2012; 73: 998-1004.
20. Wakabayashi I. Relationship between alcohol intake and lipid accumulation product in middle-aged men. Alcohol Alcohol 2013; 48: 535-542.
21. Veenstra J, Schenkel JA, van Erp-Baart AM, Brants HA, Hulshof KF, Kistemaker C et al. Alcohol consumption in relation to food intake and smoking habits in the Dutch National Food Consumption Survey. Eur J Clin Nutr 1993; 47: 482-489.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: S62-69.
23. Anonymous. Metabolic syndrome-definition and diagnostic criteria in Japan. J Jpn Soc Int Med 2005; 94: 794-809 (in Japanese).
24. Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H et al. A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects. Atherosclerosis 2012; 225: 208-215.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001; 285: 2486-2497.
26. Wakabayashi I, Daimon T. A strong association between lipid accumulation product and diabetes in Japanese women and men. J Atheroscler Thromb 2014; 21: 282-288.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
28. Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H et al., Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society (JDS). International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012; 3: 8-10.
29. Frost PH, Havel RJ. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 1998; 81: 26B-31B.
30. Sniderman A, McQueen M, Contois J, Williams K, Furberg CD. Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? J Clin Lipidol 2010; 4: 152-155.
31. Eliasson B, Cederholm J, Eeg-Olofsson K. Svensson AM, Zethelius B, Gudbjörnsdottir S; National Diabetes Register. Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register. Diabetes Care 2011; 34: 2095-2100.
32. Wakabayashi I, Groschner K. Age-dependent associations of smoking and drinking with non-high-density lipoprotein cholesterol. Metabolism 2010; 59: 1074-1081.
33. McLaughlin T, Reaven G, Abbasi F, Lamendola C, Saad M, Waters D et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005; 96: 399-404.
34. Kim JS, Kang HT, Shim JY, Lee HR. The association between the triglyceride to high-density lipoprotein cholesterol ratio with insulin resistance (HOMA-IR) in the general Korean population: based on the National Health and Nutrition Examination Survey in 2007-2009. Diabetes Res Clin Pract 2012; 97: 132-138.
35. Taverna MJ, Martínez-Larrad MT, Frechtel GD, Serrano-Ríos M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol 2011; 164: 559-567.
36. Freeman DJ, Caslake MJ, Griffin BA, Hinnie J, Tan CE, Watson TD et al. The effect of smoking on post-heparin lipoprotein and hepatic lipase, cholesteryl ester transfer protein and lecithin:cholesterol acyl transferase activities in human plasma. Eur J Clin Invest 1998; 28: 584-591.
37. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994; 106: 241-253.
38. International Diabetes Federation. Diabetes Atlas. 4th edn. 2009Available at www.diabetesatlas.org. Last accessed on 25 July 2013.
39. Sumner AE, Harman JL, Buxbaum SG, Miller BV 3rd, Tambay AV, Wyatt SB et al. The triglyceride/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in African-American women: an analysis of Jackson Heart Study. Metab Syndr Relat Disord 2010; 8: 511-514.
40. Cullen P, Schulte H, Assmann G. Smoking, lipoproteins and coronary heart disease risk. Data from the Münster Heart Study (PROCAM). Eur Heart J 1998; 19: 1632-1641.